Allarity Therapeutics, Inc. Profile Avatar - Palmy Investing

Allarity Therapeutics, Inc.

Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a …

Biotechnology
US, Cambridge [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of ALLR's Analysis
CIK: 1860657 CUSIP: 016744104 ISIN: US0167443029 LEI: - UEI: -
Secondary Listings
ALLR has no secondary listings inside our databases.